PPA
NVAX icon

Parametric Portfolio Associates’s Novavax NVAX Stock Holding History

Parametric Portfolio Associates’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.93M Sell
39,826
-49,884
-56% -$4.45M ﹤0.01% 2200
2021
Q4 		$12.8M Sell
89,710
-18,462
-17% -$3.17M 0.01% 1222
2021
Q3 		$22.4M Buy
108,172
+26,645
+33% +$5.87M 0.01% 870
2021
Q2 		$17.3M Buy
81,527
+34,307
+73% +$6.29M 0.01% 1035
2021
Q1 		$8.56M Buy
47,220
+22,876
+94% +$4.56M ﹤0.01% 1790
2020
Q4 		$2.71M Sell
24,344
-1,714
-7% -$182K ﹤0.01% 2468
2020
Q3 		$2.82M Sell
26,058
-10,587
-29% -$1.29M ﹤0.01% 2287
2020
Q2 		$3.05M Buy
36,645
+20,168
+122% +$771K ﹤0.01% 2222
2020
Q1 		$224K Buy
16,477
+6,303
+62% +$53.3K ﹤0.01% 3507
2019
Q4 		$40K Buy
+10,174
New +$44.1K ﹤0.01% 3930
2019
Q3 		– Sell
-12,825
Closed -$75K – 3983
2019
Q2 		$75K Buy
12,825
+11,313
+748% +$89K ﹤0.01% 3873
2019
Q1 		$17K Sell
1,512
-2,194
-59% -$69.3K ﹤0.01% 3919
2018
Q4 		$136K Buy
3,706
+2,677
+260% +$104K ﹤0.01% 3743
2018
Q3 		$39K Sell
1,029
-959
-48% -$27K ﹤0.01% 3919
2018
Q2 		$53K Buy
1,988
+523
+36% +$17.7K ﹤0.01% 3845
2018
Q1 		$62K Buy
+1,465
New +$58.9K ﹤0.01% 3893
2017
Q1 		– Sell
-928
Closed -$23K – 3806
2016
Q4 		$23K Sell
928
-1,656
-64% -$48.3K ﹤0.01% 3759
2016
Q3 		$107K Sell
2,584
-3,227
-56% -$417K ﹤0.01% 3667
2016
Q2 		$845K Buy
5,811
+1,831
+46% +$210K ﹤0.01% 2940
2016
Q1 		$411K Buy
3,980
+672
+20% +$72.1K ﹤0.01% 3433
2015
Q4 		$555K Buy
3,308
+2,375
+255% +$366K ﹤0.01% 3181
2015
Q3 		$132K Buy
933
+49
+6% +$11K ﹤0.01% 3159
2015
Q2 		$197K Buy
884
+249
+39% +$43.8K ﹤0.01% 3773
2015
Q1 		$105K Buy
+635
New +$103K ﹤0.01% 3855
2014
Q4 		– Sell
-1,537
Closed -$128K – 3997
2014
Q3 		$128K Buy
+1,537
New +$139K ﹤0.01% 3687

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Parametric Portfolio Associates's NVAX Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Novavax (NVAX) stake by 56% in Q1 2022, selling an estimated $4.45M and leaving 39,826 shares worth $2.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2200.

Parametric Portfolio Associates first reported a position in NVAX in Q3 2014 and has held it in 25 quarters since. The position peaked at $22.4M in Q3 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Parametric Portfolio Associates held 39,826 shares of Novavax worth $2.93M as of Q1 2022.
  • Parametric Portfolio Associates sold 49,884 Novavax shares in Q1 2022, an estimated $4.45M.
  • Novavax made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2200 holding.
  • Parametric Portfolio Associates first reported a position in Novavax in Q3 2014 and has held it in 25 quarters since.
  • Parametric Portfolio Associates's Novavax position peaked at $22.4M in Q3 2021.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.